Chemotherapy in Neonates and Infants with Cancer and Other Congenital Diseases: Down Syndrome and HIV

  • Carolina Witchmichen Penteado Schmidt


Although patients with Down syndrome (patients who carrier trisomy 21 mosaics) may have a disposition to develop some malignancies, such as acute leukemias—with a 10- to 20-fold increased risk of developing this kind of disease—they have a markedly decreased incidence of solid tumors. These patients also have a particular profile of treatment-related toxicities [72, 73].


  1. 72.
    Rabin KR, Whitlock JA. Malignancy in children with trisomy 21. Oncologist. 2009;14(2):164–73.CrossRefGoogle Scholar
  2. 73.
    Massey GV, Zipursky A, Chang MN, et al. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children’s Oncology Group (COG) study POG-9481. Blood. 2006;107:4606–13.CrossRefGoogle Scholar
  3. 99.
    Xiong H, Ha SY, Chiang AKS, et al. A small cohort review of neonatal transient myeloproliferative disease in Chinese children. HK J Paediatr. 2011;16:258–63.Google Scholar
  4. 98.
    McClain KL, Joshi VV, Murphy SB. Cancers in children with HIV infection. Hematol Oncol Clin North Am. 1996;10(5):1189–201.CrossRefGoogle Scholar
  5. 96.
    Berkowitz R, Frenkel LM. Cancer in the HIV infected child. Pediatr Dent. 1996;18:2. Google Scholar
  6. 97.
    Manji KP, Amir H, Maduhu IZ. Aggressive Kaposi’s sarcoma in a 6-months-old African infant: case report and review of the literature. Trop Med Int Health. 2000;5(2):85–7.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Carolina Witchmichen Penteado Schmidt
    • 1
  1. 1.CuritibaBrazil

Personalised recommendations